Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Class IIDrug

Clear Eyes Redness Relief recall

Summary

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company is recalling Clear Eyes Redness Relief (drug). According to the FDA report, the reason is: Lack of Assurance of Sterility. The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.

Details from the FDA report

Product
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason
Lack of Assurance of Sterility
Lot / code info
Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.
Quantity
Not listed
Distribution
Nationwide in the USA.
Recalling company
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY United States
Recall started
September 15, 2026
FDA report date
September 30, 2026
Classification
Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number
D-0871-2026

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.